-
Diagnostics World | CEO Gordan Sanghera gave Oxford Nanopore’s first live presentation at the JP Morgan Healthcare Conference last week. He highlighted his platforms accuracy and the company’s consumable growth.
Jan 16, 2024
-
Diagnostics World | Christian Henry, President and CEO of Pacific Biosciences, was unabashedly cheerful at the JP Morgan Healthcare Conference on Wednesday afternoon when he gave the updates for PacBio. “2023 absolutely exceeded our expectations,” he said, basking in two platform launches, strong consumable growth, and three new platforms in development.
Jan 12, 2024
-
Diagnostics World | CEO Jacob Thaysen presented Illumina’s updates yesterday at the JP Morgan Healthcare Conference. 2023 has been an eventful year for the sequencing pioneer with December’s announcement that Illumina would divest GRAIL; Francis deSouza, Illumina’s former CEO, stepping down in June; and $175M in cost cuts over the course of 2023 which included headcount reductions and major real estate changes. Thaysen presented Illumina at a turning point.
Jan 9, 2024
-
Diagnostics World | In a turnaround of the usual metabolomics study approach, University of California San Diego scientists are homing in on the microbial-produced molecules that interact with cells and affect human health. A couple million such molecules are likely awaiting discovery in this fashion.
Jan 9, 2024
-
Diagnostics World | AI took center stage in diagnostics stories in 2023, assessing breast cancer prognoses and helping identify biomarkers. But it’s also under the microscope as researchers seek to validate “black box” AI findings. Plus: news from Illumina and a call for more diverse cystic fibrosis screening. Here’s a look at the top stories from Diagnostics World as well as thought leaders in the industry.
Jan 4, 2024
-
Diagnostics World | To kick off the New Year, we spoke with leaders and experts in the Diagnostic World community about their insights and predictions for 2024.
Jan 3, 2024
-
Diagnostics World | PerkinElmer has acquired Covaris; Revvity has launched its EONIS Q system, which can help test for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.
Dec 28, 2023
-
Diagnostics World | PCORI approves funding awards meant to fill evidence gaps related to multiple different illnesses; Apple Tree Partners will expand its portfolio company Deep Apple Therapeutics to rapidly discover novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries; Pepper Bio, the “Google Maps for drug discovery,” plans to accelerate its transomics platform capabilities, fueling the pipeline for more accurate and accessible drug discovery; and more.
Dec 27, 2023
-
Diagnostics World | There is mounting evidence that epigenetics—the molecular processes that influence how genes are expressed—is an equally if not more important driver of disease conditions and phenotypic differences than genetics. That means that accelerating the shift from reactionary medicine to preventive care is going to require biomarkers of these heritable and reversible changes.
Dec 21, 2023
-
Diagnostics World | A decade ago, the National Institutes of Health (NIH) launched a program designed to answer fundamental questions about extracellular RNA (exRNA), such as how it is used by cells and distant organs and if diseased and healthy cells produce different varieties of it. The program concludes at the end of this year but leaves science with technologies to address some of the biggest bottlenecks encountered by researchers in the niche field of study
Dec 19, 2023
-
Diagnostics World | On Sunday, Illumina announced that the company will divest GRAIL.
Dec 17, 2023
-
Diagnostics World |An international research consortium led by scientists from LMU University Hospital Munich has tested a new simple, rapid tuberculosis test that uses a blood sample from the fingertip. The candidate test, called the Cepheid Mycobacterium tuberculosis Host Response prototype cartridge (MTB-HR), works by measuring a three-gene transcriptomic signature.
Dec 14, 2023
-
Diagnostics World |Researchers at the CNIO (Spanish National Cancer Research Centre) are forwarding the idea that metastasis, rather than the primary tumor, should be the focus of cancer treatment, which would both further the cause of personalized medicine and generate biomarkers of sensitivity or resistance to specific drugs.
Dec 13, 2023
-
Diagnostics World |An international research consortium led by scientists from LMU University Hospital Munich has tested a new simple, rapid tuberculosis test that uses a blood sample from the fingertip. The candidate test, called the Cepheid Mycobacterium tuberculosis Host Response prototype cartridge (MTB-HR), works by measuring a three-gene transcriptomic signature.
Dec 12, 2023
-
Diagnostics World | Cytovale will bring its rapid sepsis diagnosis test to more hospital emergency departments (ED) and health systems in the United States; Elucid intends to expand its commercialization efforts to provide physicians and patients with critical information to combat heart disease; Flashpoint Therapeutics to advance its programs on Oncology, Peptide Therapeutics, and CRISPR; more.
Dec 7, 2023
-
Diagnostics World | Cytovale will bring its rapid sepsis diagnosis test to more hospital emergency departments (ED) and health systems in the United States; Elucid intends to expand its commercialization efforts to provide physicians and patients with critical information to combat heart disease; Flashpoint Therapeutics to advance its programs on Oncology, Peptide Therapeutics, and CRISPR; more.
Dec 5, 2023
-
Diagnostics World | Cytovale will bring its rapid sepsis diagnosis test to more hospital emergency departments (ED) and health systems in the United States; Elucid intends to expand its commercialization efforts to provide physicians and patients with critical information to combat heart disease; Flashpoint Therapeutics to advance its programs on Oncology, Peptide Therapeutics, and CRISPR; more.
Nov 30, 2023
-
Diagnostics World | Illumina enters a multi-year agreement with Veracyte to develop and offer some of its high-performing molecular tests as decentralized in vitro diagnostic (IVD) tests on Illumina’s NextSeq 550Dx next-generation sequencing (NGS) instrument; Boston Scientific Corporation acquires Relievant Medsystems to add to chronic pain portfolio; Oxford Nanopore Technologies and Fabric Genomics collaborate to develop a software solution analysis and clinical reporting of rich genomic data for faster insights to support rapid disease characterization of babies and children with genetic disorders in acute settings; more.
Nov 29, 2023
-
Diagnostics World | Investigators at Cedars-Sinai Medical Center are looking to minimize the biases in the data used by artificial intelligence (AI) algorithms, most recently a deep learning model trained on nearly a million electrocardiograms (ECGs) to identify people with abnormal heart rhythms.
Nov 28, 2023
-
Diagnostics World | Cystic fibrosis (CF) is one of the few genetic disorders to be considered both serious and common enough to merit universal carrier or prenatal screening. Unfortunately, though, current testing approaches are caught between evolution and revolution even as they continue to produce suboptimal results for people of non-European ancestry.
Nov 21, 2023